US EditionPublished • loading... • Updated
Weight Loss Drug Does Not Slow Alzheimer’s, Says Drug Maker
Summary by thecareruk.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Weight Loss Drug Does Not Slow Alzheimer’s, Says Drug Maker
Share Post Share Email A widely-used diabetes and weight-loss medication has failed to slow cognitive decline in people with early Alzheimer’s disease, pharmaceutical company Novo Nordisk has announced. The company’s study tested semaglutide – sold under the brand names Ozempic and Wegovy – in people with mild cognitive impairment or mild dementia caused by Alzheimer’s disease. Despite hopes that the drug might…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
